A straw for paediatrics: How to administer highly dosed, bitter tasting paracetamol granules

Tilen Simšič1, Boris Nolimal2, Jasmina Minova1

  • 1Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia; Alterno Labs d.o.o., Brnčičeva 29, 1231 Ljubljana-Črnuče, Slovenia.

Insights

Developing palatable paracetamol particles for pediatric use, this study created a novel drug-eluting straw. Granulated coated particles mask the bitter taste, improving medication adherence for children and patients with swallowing difficulties.

Area of Science:

  • Pharmaceutical Technology
  • Pediatric Drug Delivery
  • Taste Masking

Background:

  • Pediatric drug formulations require age-appropriate dosage forms.
  • Swallowing difficulties are common in children and some patient groups.
  • A novel drug-eluting straw offers a potential solution for administering liquid medications.

Purpose of the Study:

  • To develop palatable, granulated coated paracetamol particles for a novel drug-eluting straw.
  • To ensure effective taste masking during sipping and immediate drug release in the stomach.
  • To optimize particle properties for easy drug consumption via the straw.

Main Methods:

  • Paracetamol crystals were coated with various polymers for taste masking.
  • Coated crystals were granulated with a trehalose-erythritol mixture.
  • Particles were evaluated for taste-masking duration, liquid volume, and vacuum requirements.
  • Dissolution tests were performed in aqueous and acidic media to assess drug release.

Main Results:

  • Granulated coated paracetamol particles using Kollicoat IR or Kollicoat Protect showed promising results.
  • These particles provided taste-masking during simulated sipping.
  • Immediate release of paracetamol was confirmed in acidic conditions (85% in <30 min at pH 1.2, 4.5).

Conclusions:

  • Optimized granulated coated paracetamol particles are suitable for the novel drug-eluting straw.
  • This formulation effectively masks paracetamol's bitter taste.
  • The developed system facilitates pediatric drug administration and improves patient compliance.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
72
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
74
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64